Targeting Notch3 to treat multiple myeloma
Targeting Notch3 for the treatment of multiple myeloma
This study is looking at how blocking a protein called Notch3 might help people with multiple myeloma by slowing down tumor growth and reducing bone problems, with the hope of making current treatments work better and cause fewer side effects.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-10892640 on NIH RePORTER |
What this research studies
This research investigates the role of Notch3, a specific receptor involved in cell communication, in the treatment of multiple myeloma, a type of blood cancer. The study aims to understand how inhibiting Notch3 can reduce tumor growth and bone disease associated with multiple myeloma, which is known for its high relapse rates and resistance to existing therapies. By focusing on Notch3, the researchers hope to improve the effectiveness of current treatments and reduce side effects. The approach includes evaluating the impact of Notch3 inhibition on tumor growth and patient responses to standard therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with multiple myeloma who are seeking new treatment options.
Not a fit: Patients with other types of cancers or those who do not have multiple myeloma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for multiple myeloma, improving patient outcomes and quality of life.
How similar studies have performed: Previous research has shown promise in targeting Notch signaling in cancer treatment, suggesting that this approach could be effective.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Sabol, Hayley — Univ of Arkansas for Med Scis
- Study coordinator: Sabol, Hayley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.